These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1915651)

  • 1. The role of plasmapheresis in Graves' ophthalmopathy.
    Glinoer D
    Exp Clin Endocrinol; 1991 May; 97(2-3):328-31. PubMed ID: 1915651
    [No Abstract]   [Full Text] [Related]  

  • 2. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange therapy for severe Graves' ophthalmopathy.
    Glinoer D; Schrooyen M; Winand R
    Dev Ophthalmol; 1989; 20():91-3. PubMed ID: 2591631
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of plasmapheresis in a case of Graves' disease with malignant ophthalmopathy (author's transl)].
    Glinoer D; Gaham N; Sand G; Libert J; Grivegnee A; Badjou R; Ermans AM
    Ann Endocrinol (Paris); 1981 Dec; 42(6):545-6. PubMed ID: 6896620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detectable serum IgE levels in Graves' ophthalmopathy.
    Molnár I; Horváth S; Balázs C
    Eur J Med Res; 1996 Sep; 1(11):543-6. PubMed ID: 9438158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment by plasmapheresis of progressive edematous-infiltrative ophthalmopathy after corticotherapy failure].
    Pilarska K; Syrenicz A
    Pol Tyg Lek; 1987 Sep; 42(39):1230-1. PubMed ID: 3325947
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunomodulatory treatment of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM
    Thyroid; 1998 Jun; 8(6):545-8. PubMed ID: 9669295
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic aspects of Graves' ophthalmopathy. Therapeutic role of plasma exchange].
    Morosini PP; Salvi A; Marchegiani G; Maniscalco L
    Minerva Endocrinol; 1984; 9(1):25-30. PubMed ID: 6548795
    [No Abstract]   [Full Text] [Related]  

  • 9. Toward better models of hyperthyroid Graves' disease.
    Dağdelen S; Kong YC; Banga JP
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):343-54, viii. PubMed ID: 19328415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of antibodies in Graves' ophthalmopathy].
    Molnár I; Balázs C
    Orv Hetil; 1991 Sep; 132(38):2097-100. PubMed ID: 1923482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' ophthalmopathy and dermopathy. Preface.
    Wiersinga WM
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):227. PubMed ID: 22632360
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of Graves' ophthalmopathy.
    Austin MW; Atta HR
    Br J Hosp Med; 1992 Nov 18-Dec 1; 48(10):644-9. PubMed ID: 1458273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR associations with Graves' disease in eastern Hungary.
    Stenszky V; Kozma L; Balazs C; Farid NR
    Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of malignant exophthalmos with plasmapheresis].
    Yamamoto K; Hirose M; Masuno M; Saito K; Sakamoto Y; Kuzuya T; Yoshida S; Mutoh Y
    Nihon Naika Gakkai Zasshi; 1982 Jul; 71(7):967-71. PubMed ID: 6897415
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of endocrine ophthalmopathy].
    Pfannenstiel P; Utech C; Wulle KG
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1331-3. PubMed ID: 3755678
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma leptin concentrations in patients with Graves' disease with or without ophthalmopathy.
    Ozata M; Uckaya G; Bolu E; Corapcioglu D; Bingol N; Ozdemir IC
    Med Sci Monit; 2001; 7(4):696-700. PubMed ID: 11433197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute ataxia, Graves' disease, and stiff person syndrome.
    Chia SY; Chua R; Lo YL; Wong MC; Chan LL; Tan EK
    Mov Disord; 2007 Oct; 22(13):1969-71. PubMed ID: 17712846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.